Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Arthritis, Psoriatic 2Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × guselkumab × Clear all
NCT03649971 2025-02-03

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Janssen Research & Development, LLC

Phase 1 Completed
77 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT03796858 2025-02-03

COSMOS

Janssen Pharmaceutica N.V., Belgium

Phase 3 Completed
285 enrolled

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed
383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡